Irmandade da Santa Casa de Misericordia de Sao Paulo

1 marketed · 2 in Phase 3

Quick facts

Marketed products

Phase 3 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Irmandade da Santa Casa de Misericordia de Sao Paulo

What are Irmandade da Santa Casa de Misericordia de Sao Paulo's marketed drugs?

Top marketed products include Cimicifuga racemosa.

What is Irmandade da Santa Casa de Misericordia de Sao Paulo's pipeline?

Irmandade da Santa Casa de Misericordia de Sao Paulo has 2 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include clonidine gel 1%, ketamine + clonidine.

Related